Inflazome, a biotech company developing new drugs to block harmful inflammation, has secured further investment of $63 million.
28 November 2018Search UQ News
Inflazome, a biotech company developing new drugs to block harmful inflammation, has secured further investment of $63 million.
28 November 2018
Privacy & Terms of use | Feedback
Authorised by: Director, Office of Marketing and Communications
ABN: 63 942 912 684
CRICOS
Provider No: 00025B